FDA Inspection 717247 — WraSer Pharmaceuticals, LLC

WraSer Pharmaceuticals, LLC — FEI 3005966693

The FDA completed an inspection of WraSer Pharmaceuticals, LLC on Mar 25, 2011 in Ridgeland, MS. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 25, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ridgeland, MS (United States)